A company executive said this week it has begun production and expects to have 30 million doses ready for U.S. distribution, once it’s approved by the U.S.
If the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.